|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Translational Research Center, Kyoto University Hospital, Kyoto, Kyoto, Japan
2 Translational Research Center, Kyoto University Hospital, Kyoto, Japan
3 Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
4 Department of Pathology and Biology of Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan
5 Translational Research Center, Kyoto University Hospital, Kyoto, Japan; Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
* To whom correspondence should be addressed. E-mail: seino{at}med.kobe-u.ac.jp.
We recently found that pancreatic acinar cells isolated from normal adult mouse can transdifferentiate into insulin-secreting cells in vitro. Using two different animal models of type 1 diabetes, we show here that insulin-secreting cells also can be generated from pancreatic acinar cells of mice in the diabetic state with absolute insulin deficiency. When pancreatic acinar cells of streptozotocin-treated mice were cultured in suspension in the presence of epidermal growth factor and nicotinamide under low-serum condition, expressions of insulin genes gradually increased. In addition, expressions of other pancreatic hormones including glucagon, somatostatin, and pancreatic polypeptide also were induced. Analysis by the Cre/loxP-based direct cell lineage tracing system revealed that these newly made cells originated from amylase-expressing pancreatic acinar cells. Insulin secretion from the newly made cells was significantly stimulated by high glucose and other secretagogues. In addition, insulin-secreting cells were generated from pancreatic acinar cells of Komeda diabetes-prone rats, another animal model of type 1 diabetes. The present study demonstrates that insulin-secreting cells can be generated by transdifferentiation from pancreatic acinar cells of mice in the diabetic state, and further suggests that pancreatic acinar cells represent a potential source of autologous transplantable insulin-secreting cells for treatment of type 1 diabetes.
This article has been cited by other articles:
![]() |
T. L. Jetton, B. Everill, J. Lausier, V. Roskens, A. Habibovic, K. LaRock, A. Gokin, M. Peshavaria, and J. L. Leahy Enhanced {beta}-cell mass without increased proliferation following chronic mild glucose infusion Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E679 - E687. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |